Official recall notice

FDA DrugClass IINotable

Biospectra Tris/Tromethamine Recall (Oct 2026)

Product: Biospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Majestic Way, Bangor, PA 18013, NDC 64173-101-25

Recall date
2026-10-14
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Failed stability specifications

One email a week when there are new recalls. Confirm by email; unsubscribe anytime.

Product description

Failed stability specifications

Affected products

Lot#: TRIS -E04-0226-0016; Exp 2/29/28

Verify with the official notice →
Share:

Related Recalls

2026-10-21 · FDA_DRUG
FDA Recall: No Brand Name: Compounded veterinary medications
No Brand Name
2026-10-14 · FDA_DRUG
FDA Recall: Tri-MIX (PAPAV/PHENTO/ALPROS),30/1/10, injectable, Packaged in single-use dosage syringes, total mL
Carolina Infusion, LLC
2026-10-14 · FDA_DRUG
FDA Recall: TIRZEPATIDE/CYANOCOBALAMIN 26/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL d
Carolina Infusion, LLC
2026-10-14 · FDA_DRUG
FDA Recall: Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ (15 mL); a) LEADER, DISTRIBUTED BY CARDINAL HE
K.C. Pharmaceuticals, Inc.